- Live market news
- Stocks
- LABT
Lakewood-Amedex Biotherapeutics, Inc.
LABTStockUnited States
Latest news on LABTranked by Oyticker for market impact
- 15Impact
LABT to present at October biotech conferences
Lakewood-Amedex Biotherapeutics announced participation in October conferences as a clinical-stage biotech company. Conference attendance is a routine investor-relations activity with limited direct market impact.
LABTBiotechnologyPharmaceuticals - 45Impact
LABT reports positive in vitro data against diabetic foot ulcer isolates
Lakewood-Amedex Biotherapeutics announced positive laboratory data demonstrating efficacy of its therapeutic candidate against clinical bacterial isolates from infected diabetic foot ulcers, a preclinical validation step for its pipeline.
LABTBiotechnologyPharmaceuticalsHealthcare
What LABT filed
- 10 Nov 2026
Investor communication
- 28 Sept 2026
- 18 Sept 2026
- 13 Aug 2026
- 10 Aug 2026
- 15 Jul 2026
- 17 Jun 2026
Bylaws or fiscal year changed
- 22 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.